Zymeworks (NYSE:ZYME) came into focus in late December when major shareholder EcoR1 Capital increased its stake. Already a 10% holder and board member, EcoR1 made several purchases in December and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback